US Measles Cases in 2026 Approach 2025's Multi-Decade High as Formal Elimination-Status Review Nears

Cases Climb Back Toward a Multi-Decade High

As of July 16, 2026, the Centers for Disease Control and Prevention had tallied roughly 2,260 confirmed measles cases nationwide for the year, spread across 44 jurisdictions^[1][5]. That figure is already approaching the 2,289 cases recorded in all of 2025 — itself the highest annual US total since 1991, some 33 years earlier^[1][15]. Much of the current surge traces back to an outbreak that began in Gaines County, in West Texas, on January 20, 2025, and then spread into neighboring states^[11][14]. Before Texas declared that outbreak over in August 2025, it had produced 762 cases, 99 hospitalizations, and two child deaths^[14].

The backdrop to those numbers is a steady erosion in childhood vaccination. Two-dose MMR coverage among US kindergartners fell from 95.2% in the 2019-20 school year to 92.5% in 2024-25 — below the roughly 95% threshold public health researchers say is needed to stop measles from spreading through a community^[1][15]. About 92% to 94% of this year's cases occurred in people who were unvaccinated or whose vaccination status was unknown^[1][6].

Layered on top of the case counts is a bureaucratic deadline with real symbolic weight. The United States has held "measles elimination" status since 2000, a designation that requires avoiding any continuous chain of transmission for 12 months or longer^[4][5]. Because the West Texas outbreak was followed by sustained further spread, the Pan American Health Organization's Regional Verification Commission is scheduled to formally review whether the US — along with Mexico — still qualifies, at a meeting in November 2026 that was originally set for April^[2][3]. Several public health analysts describe it as "highly likely" the country will lose the designation^[2].

What Isn't in Dispute

Across every outlet examined, from the CDC's own data tables to opinion columns, a common set of facts holds steady. Measles was declared eliminated in the US in 2000 on the strength of the 12-month transmission rule^[4][5]. The 2025 case total of roughly 2,289 is the highest since 1991^[1][15]. Kindergarten MMR coverage has slipped from 95.2% to 92.5% over five years^[1][15], and the vast majority of recent cases involve people who were unvaccinated or of unknown status^[1][6].

It is also uncontested that PAHO pushed its review of US and Mexican elimination status from April to November 2026^[2][3], and that the Trump administration itself requested that postponement. An HHS spokesman told the Washington Examiner the delay was meant "to allow ... a thorough and transparent assessment ... including comprehensive genomic sequencing and advanced analysis"^[7]. Separately, in June 2025, Health Secretary Robert F. Kennedy Jr. replaced all 17 members of the CDC's Advisory Committee on Immunization Practices^[8]. One fact that has drawn less attention in the current coverage: PAHO had already stripped the broader Americas region of its regional measles-free verification in November 2025, after determining that Canada had sustained endemic transmission for more than 12 months. Every other country in the region, PAHO said at the time, kept its individual elimination status^[18] — meaning the November 2026 review is a narrower, US-specific determination layered on top of a regional status that was already lost.

The Arithmetic and the Money Underneath

Measles is one of the most contagious pathogens known, which means the fight over its return is, at bottom, a fight over a number: roughly 95% vaccination coverage is what breaks transmission chains. At 92.5% and falling, outbreaks follow as a mechanical consequence of the math, regardless of who occupies the health secretary's office^[1][15].

That arithmetic collides with a second pressure — the political weight of a 25-year-old milestone. Losing the elimination status under a health secretary long associated with vaccine skepticism would be a potent story for either party to tell, which is part of why the timing and framing of the PAHO review have become their own battleground, arguably more contested than the raw case counts themselves^[6][7].

A third pressure is fiscal. Outbreak surveillance and containment run through state and local health budgets, and reduced federal funding narrows the very capacity needed to catch and stop transmission before it becomes "continuous" under PAHO's test. California officials, for instance, say nearly $1 billion in federal cuts in 2025, plus an attempted $600 million clawback, forced clinic closures and layoffs in the middle of active outbreaks^[17]. One industry-adjacent estimate from the American Academy of Pediatrics projects that declining vaccination could cost the US $7.8 billion by 2030^[16].

How the Administration and Its Critics See the Same Numbers

Mainstream public health voices — career CDC scientists, pediatric and infectious-disease groups, and PAHO itself — treat the resurgence as predictable rather than mysterious: contagious disease returns when coverage falls below the threshold that stops it, and elimination status is a measurable epidemiological fact, not an honorary title. In this framing, the tools that ended endemic measles in 2000 — unambiguous vaccine endorsement and stable public health funding — are the same tools that could stop it now^[1][4][15].

Kennedy and HHS leadership offer a different account. Kennedy has said he has "never been anti-vaccine," that HHS "promotes the MMR" and advises children to get it, and that declining trust in vaccines and institutions predates his tenure^[7][9]. He has also pointed to undervaccinated arrivals from countries without elimination status as a driver of outbreak clusters, arguing that immigration policy, not his own messaging, deserves scrutiny — and that a status label set by an international commission should not dictate domestic policy^[7][9]. Critics, including HuffPost, have characterized that immigration-linked explanation as "xenophobic"^[11], while a Newsweek opinion piece argued Kennedy is "undermining the response"^[12]; both characterizations are attributed to those outlets rather than established as fact.

Democratic state officials and other administration critics argue the resurgence is a foreseeable outcome of federal choices — a health secretary who has sown vaccine doubt, an overhauled CDC advisory panel, and funding clawbacks hitting states in the middle of active outbreaks^[8][11][17]. Meanwhile, communities with lower vaccination uptake, including some close-knit religious groups at the center of the Texas outbreak, frame the issue as one of parental rights and bodily autonomy, viewing mandates and public pressure as coercive; it is largely their members who bore the outbreak's hospitalizations and the two child deaths in Texas^[11][14]. Underneath the administration's public-health argument sits an institutional stake as well: losing elimination status on Kennedy's watch would be a visible setback for an agenda he has pursued since taking office, which is part of why the request to delay the PAHO review drew added scrutiny from critics^[6][7].

How the Coverage Split

The story reads differently depending on which outlet tells it. Right-leaning coverage, exemplified by the Washington Examiner, reports the case numbers and possible status loss in straightforward terms but centers the narrative on the bureaucratic "status" label and the administration's delay request, giving more space to Kennedy's argument linking outbreaks to undervaccinated arrivals^[6][7]. Left-leaning outlets — CNN, HuffPost, and Newsweek — instead center the story on Kennedy himself: his ACIP overhaul, mixed messaging on MMR, and funding cuts, using language like "dismantle" and "xenophobic" and, in Newsweek's case, an explicit opinion piece arguing he is worsening the outbreak^[8][11][12].

PAHO's own communications, by contrast, stick to procedural language — announcing the commission's schedule and criteria without characterizing any government's conduct^[3]. Primary sources including the CDC, Texas health officials, and PAHO itself anchor the numbers that all sides agree on, stating case counts and the 12-month transmission rule without asserting that elimination status has already been lost — a determination that, as of this writing, remains PAHO's to make in November^[1][2][4].